Center-Authored Papers

Filters: Keyword is Bone Density Conservation Agents  [Clear All Filters]
B
Brunner RL, Cochrane BB, Jackson RD, Larson J, Lewis C, Limacher M, Rosal M, Shumaker S, Wallace R.  2008.  Calcium, vitamin D supplementation, and physical function in the Women's Health Initiative.. Journal of the American Dietetic Association. 108(9):1472-9. Abstract
C
Chlebowski RT, Chen Z, Cauley JA, Anderson G, Rodabough RJ, McTiernan A, Lane DS, Manson JE, Snetselaar L, Yasmeen S et al..  2010.  Oral bisphosphonate use and breast cancer incidence in postmenopausal women.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(22):3582-90. Abstract
Cummings SR, Ensrud K, Delmas PD, LaCroix AZ, Vukicevic S, Reid DM, Goldstein S, Sriram U, Lee A, Thompson J et al..  2010.  Lasofoxifene in postmenopausal women with osteoporosis.. The New England journal of medicine. 362(8):686-96. Abstract
DIPART (Vitamin D Individual Patient Analysis of Randomized Trials) Group.  2010.  Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe.. BMJ (Clinical research ed.). 340:b5463. Abstract
G
Gralow JR, Biermann SJ, Farooki A, Fornier MN, Gagel RF, Kumar RN, Shapiro CL, Shields A, Smith MR, Srinivas S et al..  2009.  NCCN Task Force Report: Bone Health in Cancer Care.. Journal of the National Comprehensive Cancer Network : JNCCN. 7 Suppl 3:S1-S32;quizS33-S35. Abstract
Gralow JR, Lipton A, Stopeck AT.  2011.  How Do We Define Efficacy in Comparing Osteoclast-Targeted Agents in Metastatic Breast Cancer? Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(26):3591-3592.
L
LaCroix AZ, Powles T, Osborne KC, Wolter K, Thompson JR, Thompson DD, Allred CD, Armstrong R, Cummings SR, Eastell R et al..  2010.  Breast cancer incidence in the randomized PEARL trial of lasofoxifene in postmenopausal osteoporotic women.. Journal of the National Cancer Institute. 102(22):1706-15. Abstract
LaCroix AZ, Powles T, Osborne KC, Wolter K, Thompson JR, Thompson DD, Allred CD, Armstrong R, Cummings SR, Eastell R et al..  2010.  Breast cancer incidence in the randomized PEARL trial of lasofoxifene in postmenopausal osteoporotic women.. Journal of the National Cancer Institute. 102(22):1706-15. Abstract
M
Manson JE, Allison MA, Carr JJ, Langer RD, Cochrane BB, Hendrix SL, Hsia J, Hunt JR, Lewis CE, Margolis KL et al..  2010.  Calcium/vitamin D supplementation and coronary artery calcification in the Women's Health Initiative.. Menopause (New York, N.Y.). 17(4):683-91. Abstract
von Moos R, Body J-J, Egerdie B, Stopeck A, Brown JE, Damyanov D, Fallowfield LJ, Marx G, Cleeland CS, Patrick DL et al..  2013.  Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid.. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 21(12):3497-507. Abstract
N
Newcomb PA, Trentham-Dietz A, Hampton JM.  2010.  Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk.. British journal of cancer. 102(5):799-802. Abstract